<\/p>\n
ROUND-TABLE 1: What‘s up <\/span><\/span><\/p>\n Chapter headline: Ongoing research at liver units Representatives from liver units will present active or planned research <\/span><\/span><\/p>\n Chapter coordination: Slovakia <\/span><\/span><\/p>\n Moderator: Lubomir Skladany <\/span><\/span><\/p>\n Faculty: Radan Bruha, Ivica Grgurevic, Peter Jarcuska, Michal Kukla, Tamara Milovanovic – Alempijevic, Maria Papp <\/span><\/span><\/p>\n Panel: Peter Banovcin, Tajana Filipec – Kanizaj, Sona Frankova, Peter Hegyi, Martin Janicko, Tomas Koller, Pavel Trunecka, Daniela Zilincanova <\/span><\/span><\/p>\n <\/p>\n 00:00<\/a> – Introduction & aims (Skladany L) <\/span><\/span><\/span><\/p>\n 12:55<\/a> – Grgurevic I (HR). Research agenda at the Liver Unit of the University Hospital Dubrava, Zagreb <\/span><\/span><\/span><\/p>\n 23:22<\/a> – Papp M (H). Albumin in the treatment of ACLD & other research topics from 2nd Dept. of Internal Medicine, Div. of Gastroenterology, Debrecen <\/span><\/span><\/span><\/p>\n 31:22<\/a> – Jarcuska P (SK). Chiolangiocarcinoma registry <\/span><\/span><\/span><\/p>\n 39:04<\/a> – Bruha R (CZ). Research agenda at the Liver Unit of the 4th Department of Medicine, Prague <\/span><\/span><\/span><\/p>\n 46:05<\/a> – Discussion, part 1 <\/span><\/span><\/span><\/p>\n 01:10:00<\/a> – Kukla M (PL). Research agenda at the Liver Unit of the University Hospital, Krakow <\/span><\/span><\/span><\/p>\n 01:15:38<\/a> – Discussion, part 2<\/span><\/span><\/span><\/p>\n <\/p>\n <\/p>\n ROUND-TABLE 2: Prediction <\/span><\/span><\/p>\n Chapter headline: Predictive models & parameters The role of predictive tools beyond classical scores (such as MELD, Child-Pugh) investigated in participating liver units in syndrom such as ACLD, ACLF, liver transplant candidates, with emphasis on laboratory markers (SERPINA 1, metabolomics [proteomics, bile acids], etc.). <\/span><\/span><\/p>\n AIM: Complement research & approximate bundles of care <\/span><\/span><\/p>\n Chapter coordination: Czech republic <\/span><\/span><\/p>\n Moderator: Jan Sperl <\/span><\/span><\/p>\n Faculty: Tajana Filipec Knizaj, Sona Frankova, Peter Hegyi, Eva Honsova, Martin Janicko, Pavel Trunecka <\/span><\/span><\/p>\n Panel: Radan Bruha, Sylvia Drazilova, Ivica Grgurevic, Michal Kukla, Ivana Mikolasevic, Martin Oliverius, Maria Papp, Libor Vitek<\/span><\/span><\/p>\n <\/p>\n 00:00<\/a><\/span> – Introduction (Sperl, J.) <\/span><\/span><\/p>\n 11:18<\/a><\/span> – Janicko P (SK) – Translation of PREDICT study to real life in SK <\/span><\/span><\/p>\n 21:23<\/a><\/span> – Frankova S (CZ) – Role of SERPINA genes <\/span><\/span><\/p>\n 31:52<\/a><\/span> – Honsova E (CZ) – Histology <\/span><\/span><\/p>\n 44:54<\/a><\/span> – Filipec Knizaj T (HR) – MELD, MELD 2.0, MELD 3.0 or other model for liver transplant listing? <\/span><\/span><\/p>\n 53:00<\/a><\/span> – Discussion<\/span><\/span><\/p>\n <\/p>\n <\/p>\n ROUND-TABLE 3: Microbiome<\/p>\n Chapter headline: Microbiome & ACLD Has microbiome analysis come of age in CE to predict & manage liver diseases. Biobanking. Centralizing analysis. Advanced technologies beyond 16SRNA. <\/span><\/span><\/p>\n Chapter coordination: Hungary <\/span><\/span><\/p>\n Moderator: Maria Papp <\/span><\/span><\/p>\n Faculty: Natalia Bystrianska, Tomas Koller, Ivana Mikolasevic, Katarina Soltys, Tomas Szemes, Libor Vitek <\/span><\/span><\/p>\n Panel: Peter Banovcin, Peter Hegyi, Michal Kukla, Peter Liptak, Marian Oltman, Marek Rac, Jan Sperl, Lucija Virovic – Jukic <\/span><\/span><\/p>\n Aim: To coordinate efforts, approximate methodologies, define areas of interest from population screening of cirrhosis to ACLF management <\/span><\/span><\/p>\n <\/p>\n 00:00<\/a><\/span> – Soltys K (SK). Microbiome in severe alcoholic hepatitis <\/span><\/span><\/p>\n 11:17<\/a><\/span> – Vitek L (CZ). Bile acids and microbiome – what\/how to study<\/span><\/span><\/p>\n 24:44<\/a><\/span> – Bystrianska N (SK). Fecal microbiota transplantation in severe alcoholic hepatitis <\/span><\/span><\/p>\n 30:13<\/a><\/span> – Koller T (SK). Calprotectin in CLD <\/span><\/span><\/p>\n 36:41<\/a><\/span> – Kukla M (PL). SIBO in liver diseases <\/span><\/span><\/p>\n 52:03<\/a><\/span> – Papp M (HU). Microb Predict.<\/span><\/span><\/p>\n <\/p>\n <\/p>\n ROUND-TABLE 4: Screening <\/span><\/span><\/p>\n Chapter headline: Screening for liver fibrosis & disease in Europe Representatives will present their involvement in existing and forthcomming\/planned screening projects in their countries <\/span><\/span><\/p>\n Chapter coordination: Croatia <\/span><\/span><\/p>\n Faculty: Ivica Grgurevic, Michal Kukla, Tamara Milovanovic – Alempijevic, Maria Papp, Lubomir Skladany, Jan Sperl, Lucija Virovic-Jukic <\/span><\/span><\/p>\n Panel: Svetlana Adamcova Selcanova, Radan Bruha, Daniel Jan Havaj, Peter Jarcuska, Marek Rac, Maria Szantova, Pavel Trunecka <\/span><\/span><\/p>\n Aim: To coordinate efforts, merge results, define burden of liver diseases in CE and put it in the wider context <\/span><\/span><\/p>\n <\/p>\n 00:00<\/a><\/span> – Skladany L. Introduction<\/span><\/span><\/p>\n 06:35<\/a><\/span> – Grgurevic I (HR). Croatia & LiverScreen <\/span><\/span><\/p>\n 20:45<\/a><\/span> – Virovi\u010d-Juki\u010d (HR). Which method(s) for mass screening of steatosis and fibrosis <\/span><\/span><\/p>\n 29:25<\/a><\/span> – Discussion, part 1 <\/span><\/span><\/p>\n 47:09<\/a><\/span> – Skladany L (SK). SIRIUS & HEP-CALCULATOR® <\/span><\/span><\/p>\n 55:50<\/a><\/span> – Discussion, part 2<\/span><\/span><\/p>\n <\/p>\n ROUND-TABLE 5: Off vogue <\/span><\/span><\/p>\n Chapter headline: Inequalities, orphan & neglected topics Gender & social inequalities in liver health, addiction research (alcohol, drugs, sugar, sedentary lifestyle & media), psychology\/typology beyond liver diseases, liver cancer, liver surgery, liver transplantation <\/span><\/span><\/p>\n Chapter coordination: Serbia, Poland <\/span><\/span><\/p>\n Moderator: Tamara Milovanovic – Alempijevic, Michal Kukla <\/span><\/span><\/p>\n Faculty: Svetlana Adamcova Selcanova, Sylvia Drazilova, Martin Oliverius, Marek Rac, Maria Szantova, Pavel Trunecka <\/span><\/span><\/p>\n Panel: Natalia Bystrianska, Tajana Filipec – Knizaj, Sona Frankova, Eva Honsova, Martin Janicko, Tomas Koller, Maria Papp, Jan Sperl <\/span><\/span><\/p>\n Aim: To st the stage, define neglected areas operative in CE liver health, coordinate efforts <\/span><\/span><\/p>\n <\/p>\n 00:00<\/a><\/span> – Introduction (Kukla M) <\/span><\/span><\/p>\n 01:58<\/a><\/span> – Milovanovic – Alempijevic T (SRB). Drug-induced liver injury: Do we know everything? <\/span><\/span><\/p>\n 10:44<\/a><\/span> – Rac M (SK). Ultra processed food and liver diseases <\/span><\/span><\/p>\n 16:43<\/a><\/span> – Drazilova (SK). Cholestatic liver diseases <\/span><\/span><\/p>\n 24:16<\/a><\/span> – Trunecka P (CZ). HCC & Liver Transplantation <\/span><\/span><\/p>\n
\n
\n
\n
\n